Queen Margaret University logo
    • Login
    View Item 
    •   QMU Repositories
    • eResearch
    • School of Health Sciences
    • Nursing
    • View Item
    •   QMU Repositories
    • eResearch
    • School of Health Sciences
    • Nursing
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Tailored dose baclofen in patients with alcoholic liver disease: A case series with 2-year follow-up of hospitalisation

    Date
    2015-11
    Author
    Heydtmann, Mathis
    Macdonald, Benn
    Lewsey, James
    Masson, Neil
    Cunningham, Leona
    Irnazarow, Aleksandra
    Nardone, Amanda
    Cosgrave, Jan
    Chick, Jonathan
    Metadata
    Show full item record
    Citation
    Heydtmann, M., Macdonald, B., Lewsey, J., Masson, N., Cunningham, L., Irnazarow, A., Nardone, A., Cosgrave, J. & Chick, J. (2015) Tailored dose baclofen in patients with alcoholic liver disease: A case series with 2-year follow-up of hospitalisation, Addiction Research & Theory, vol. 23, , pp. 510-517,
    Abstract
    Introduction: Alcohol addiction is a major health burden with its consequences including liver disease and frequent hospitalisations. We used tailored-dose baclofen in patients with alcoholic liver disease and investigated hospital re-admissions before and after baclofen dose was initiated as well as tolerability and patient-reported alcohol consumption. Methods: Fifty-three hospitalised patients with alcoholic liver disease started tailored dose baclofen (median: 5.05 months, median highest dose before tapering down: 60 mg). Patients were followed-up for hospitalisation data from the health board database (mean hospitalisation follow up: 31 months) and patients were sent standardized questionnaires. Results: Baclofen was generally well tolerated with dose reductions in four patients. In the 2 years after initiation of the treatment, patients spent on an average of 19.1 d in the hospital per year compared to 25.48 d before the treatment initiation (p = 0.59). Respondents (19 patients) reported a reduction in alcohol consumption by an average of 58.7% (240.1 g to 144.09 g). Conclusions: After initiation of the baclofen treatment, there was a trend towards decrease in hospitalisations and in patients who answered the questionnaire, alcohol consumption decreased. 2015 Informa UK Ltd. All rights reserved.
    Official URL
    http://dx.doi.org/10.3109/16066359.2015.1040003
    URI
    https://eresearch.qmu.ac.uk/handle/20.500.12289/3983
    Collections
    • Nursing

    Queen Margaret University: Research Repositories
    Accessibility Statement | Repository Policies | Contact Us | Send Feedback | HTML Sitemap

     

    Browse

    All QMU RepositoriesCommunities & CollectionsBy YearBy PersonBy TitleBy QMU AuthorBy Research CentreThis CollectionBy YearBy PersonBy TitleBy QMU AuthorBy Research Centre

    My Account

    LoginRegister

    Queen Margaret University: Research Repositories
    Accessibility Statement | Repository Policies | Contact Us | Send Feedback | HTML Sitemap